[Persistence factors of Helicobacter pylori]

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• * Helicobacter pylori (H. pylori) is a major cause of chronic gastritis and peptic ulcer disease.
• * Understanding H. pylori's mechanisms for evading host defenses is crucial for effective treatment.

Purpose of the Study:

• * To investigate the capacity of H. pylori isolates to inactivate lysozyme and human leukocytic interferon's bactericidal component (anti-intercide).
• * To determine the prevalence and significance of antilysozyme activity (ALA) and anti-intercide activity in H. pylori clinical isolates.
• * To evaluate the potential of ALA as a diagnostic marker for guiding H. pylori eradication therapy.

Main Methods:

• * Collection and characterization of H. pylori isolates from patients with chronic gastritis and peptic ulcers.
• * Assays to measure the antilysozyme activity (ALA) and anti-intercide activity of H. pylori isolates.
• * Correlation analysis of ALA expression with clinical data and inflammatory changes in gastric biopsies.
• * Retrospective analysis of clinical cases to assess ALA as a predictive marker for therapy selection.

Main Results:

• * H. pylori isolates demonstrated the ability to inactivate both lysozyme and anti-intercide.
• * Antilysozyme activity (ALA) was widely prevalent among clinical H. pylori isolates.
• * High ALA prevalence correlated with inflammatory changes in gastric mucosal biopsies, suggesting a role in pathogenesis.
• * ALA was identified as a potential indicator for selecting appropriate H. pylori eradication therapy.

Conclusions:

• * H. pylori possesses significant mechanisms to counteract host innate immunity, including lysozyme and interferon.
• * The widespread antilysozyme activity (ALA) of H. pylori supports its critical role in the development of gastric mucosal lesions.
• * ALA can serve as a valuable diagnostic criterion for optimizing H. pylori eradication strategies early in patient management.